CAM
AMED

Cresset Asset Management’s Amedisys AMED Stock Holding History

Cresset Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-451,781
Closed -$41.8M – 1446
2025
Q1 		$41.8M Sell
451,781
-497
-0.1% -$45.8K 0.21% 77
2024
Q4 		$41.1M Sell
452,278
-6,171
-1% -$567K 0.2% 79
2024
Q3 		$44.2M Buy
458,449
+2,568
+0.6% +$251K 0.17% 86
2024
Q2 		$41.8M Buy
455,881
+1,167
+0.3% +$108K 0.18% 87
2024
Q1 		$41.9M Buy
454,714
+355
+0.1% +$33.3K 0.2% 73
2023
Q4 		$43.2M Buy
454,359
+270
+0.1% +$25.2K 0.26% 53
2023
Q3 		$42.4M Buy
454,089
+167
+0% +$15.4K 0.16% 71
2023
Q2 		$41.5M Buy
453,922
+438,197
+2,787% +$35.9M 0.05% 116
2023
Q1 		$1.16M Buy
15,725
+41
+0.3% +$3.55K 0.02% 321
2022
Q4 		$1.31M Sell
15,684
-45
-0.3% -$4.06K 0.02% 261
2022
Q3 		$1.52M Sell
15,729
-64
-0.4% -$7.63K 0.02% 259
2022
Q2 		$1.66M Sell
15,793
-2,000
-11% -$256K 0.02% 257
2022
Q1 		$3.07M Sell
17,793
-236
-1% -$35.3K 0.03% 191
2021
Q4 		$2.92M Buy
+18,029
New +$2.9M 0.03% 233
2019
Q2 		– Sell
-832
Closed -$103K – 528
2019
Q1 		$103K Buy
832
+828
+20,700% +$104K ﹤0.01% 546
2018
Q4 		$0 Buy
+4
New +$471 ﹤0.01% 1694

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Cresset Asset Management's AMED Position: Q2 2025 in Review

Cresset Asset Management sold out of Amedisys (AMED) in Q2 2025, closing a stake of 451,781 shares — an estimated $41.8M sold.

Cresset Asset Management first reported a position in AMED in Q4 2018 and held it in 16 quarters. The position peaked at $44.2M in Q3 2024. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

  • Cresset Asset Management reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
  • Cresset Asset Management sold 451,781 Amedisys shares in Q2 2025, an estimated $41.8M.
  • Cresset Asset Management first reported a position in Amedisys in Q4 2018 and held it in 16 quarters.
  • Cresset Asset Management's Amedisys position peaked at $44.2M in Q3 2024.
  • 319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on Cresset Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.